David Nicolas Debruyne

David Nicolas Debruyne

Auto-generated profile, based on publicly available information

David Nicolas Debruyne

Pediatric Oncology, Dana-Farber Cancer Institute

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
There is great interest in understanding how the cancer stem cell population may be maintained in solid tumors. Here, we show that tumor cells exhibiting stem-like properties and expression of pluripotency markers NANOG and OCT4 can arise from original differentiated tumor cells freshly isolated from human glioblastomas (GBM) and that have never known any serum culture conditions. Induction of EGR1 by EGFR/ERK signaling promoted cell conversion from a less aggressive, more differentiated cellular state to a self-renewing and strongly tumorigenic state, expressing NANOG and OCT4. Expression of these pluripotency markers occurred before the cells re-entered the cell cycle, demonstrating their capacity to change and dedifferentiate without any cell divisions. In differentiated GBM cells, ERK-mediated repression of miR-199a-3p induced EGR1 protein expression and triggered dedifferentiation. Overall, this signaling pathway constitutes an ERK-mediated "toggle switch" that promotes pluripotency marker expression and stem-like features in GBM cells. Significance: This study defines an ERK-mediated molecular mechanism of dedifferentiation of GBM cells into a stem-like state, expressing markers of pluripotency. See related commentary by Koncar and Agnihotri, p. 3195

31 March 2023
Verified
Other
Open access
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
These figures describe egfr expression and amplification in the original tumors and patient-derived GSC (sup fig 1); spheroid formation (sup fig 2); magnification of figure 1b (sup fig 3), stem-like and tumorigenic properties of the resulting spheroids (sup fig 4).

31 March 2023
Verified
Other
Open access
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
This text corresponds to the legends of supplemental tables 1 to 3 and supplemental figures 1 to 14

31 March 2023
Verified
Other
Open access
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
These figures describe the identification of three clusters of genes that are regulated by ERK upon EGF-mediated dedifferentiation (sup fig 8) and the probability of survival of patients expressing these clusters at a level above or below the median of expression (sup fig 9).

31 March 2023
Verified
Other
Open access
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
The supplemental figure 12 describes EGR1 expression during cell dedifferentiation. The supplemental figure 13 descries miR-199a-3p conserved sites in EGR1 3'UTR. The supplemental figure 14 describes the effects of shEGR1 and synthetic miR-199a-3p on EGR1 and miR-199a-3p expression and the consequence on NANOG expression.

31 March 2023
Verified
Other
Open access
FAFabien Almairac
Fabien Almairac
LTLaurent Turchi
Laurent Turchi
NSNathalie Sakakini
Nathalie Sakakini
DDDavid Nicolas Debruyne
David Nicolas Debruyne
SESarah Elkeurti
Sarah Elkeurti
TVThierry Virolle
Thierry Virolle
This figure describes EGR1, OLIG2, KI67 and GFAP expression in mitotic and not-mitotic GBM territories.